Skip to main content
. Author manuscript; available in PMC: 2023 Jun 2.
Published in final edited form as: Nat Metab. 2022 Jun 2;4(5):524–533. doi: 10.1038/s42255-022-00565-1

Extended Data Fig. 6 |. Effects of itaconate and mesaconate are independent of GsH.

Extended Data Fig. 6 |

a. Cytokine secretion of BMDMs from wildtype mice pre-treated with 10 mM itaconate or mesaconate, or 0.25 mM DMI, in the presence or absence of 1 mM cellular permeable GSH (EtGSH) for 4 h prior to LPS stimulation for 21 h. b,c. Cytokine secretion (b), glucose uptake and lactate secretion (c) of Gclc-deficient (Gclc-KO) BMDMs pre-treated with 10 mM itaconate or mesaconate for 4 h prior to LPS stimulation for 21 h. Data are shown as: a. mean ± SEM calculated from n = 4 mice; b,c. mean with individual mouse data pooled from n = 6 (b) or 3 (c) mice, and conditions from individual mouse are connected with a line. P values were calculated by multiple unpaired t-test (a) or paired t-test (b,c, paired by each mouse) and overlayed on respective comparisons.